Differential expression of GRK isoforms in nonmalignant and malignant human granulosa cells

Denise Walker King1, Rosemary Steinmetz, Heather A Wagoner

  • 1Section of Pediatric Endocrinology/Diabetology, Department of Pediatrics, Physiology and Biophysics, Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202, USA.

Endocrine
|December 11, 2003
PubMed

Insights

Altered expression of G-protein coupled receptor kinases (GRKs) was observed in granulosa cell tumors (GCTs). These GRK alterations may play a role in the development of these serious ovarian neoplasms.

Area of Science:

  • Oncology
  • Molecular Biology
  • Endocrinology

Background:

  • Granulosa cell tumors (GCTs) are significant ovarian neoplasms with largely unknown pathogenesis.
  • G-protein coupled receptor kinases (GRKs) regulate G-protein coupled receptor signaling, including the follicle stimulating hormone receptor (FSHR) crucial for granulosa cell function.

Purpose of the Study:

  • To investigate the expression of GRK mRNA and protein in human granulosa cells and GCTs.
  • To determine if GRK expression patterns differ between nonmalignant granulosa cells and GCTs.

Main Methods:

  • Analysis of GRK mRNA and protein expression in nonmalignant human granulosa cells, the KGN GCT cell line, and human GCT tissue samples.
  • Comparison of GRK expression levels between different cell types and tumor samples.

Main Results:

  • KGN GCT cells showed significantly lower GRK4 alpha/beta protein and higher GRK2 and GRK4 gamma/delta protein compared to nonmalignant granulosa cells.
  • GRK4 alpha/beta protein was detected in only 3 of 13 human GCT samples, while GRK4 gamma/delta proteins were present in all samples.

Conclusions:

  • GRK protein expression is significantly altered in granulosa cell tumors.
  • These observed GRK alterations suggest a potential role in the pathogenesis of GCTs.